IPIX (Innovation Pharmaceuticals) Interest Expense: $-0.06 Mil (TTM As of Sep. 2023)


What is Innovation Pharmaceuticals Interest Expense?

Innovation Pharmaceuticals IPIX Interest Expense is $-0.06 Mil as of Sep. 2023.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Innovation Pharmaceuticals's interest expense for the three months ended in Sep. 2023 was $ -0.01 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.06 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Innovation Pharmaceuticals's Operating Income for the three months ended in Sep. 2023 was $ -0.80 Mil. Innovation Pharmaceuticals's Interest Expense for the three months ended in Sep. 2023 was $ -0.01 Mil. Innovation Pharmaceuticals did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Innovation Pharmaceuticals  (OTCPK:IPIX) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Innovation Pharmaceuticals's Interest Expense for the three months ended in Sep. 2023 was $-0.01 Mil. Its Operating Income for the three months ended in Sep. 2023 was $-0.80 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2023 was $0.00 Mil.

Innovation Pharmaceuticals's Interest Coverage for the quarter that ended in Sep. 2023 is calculated as

Innovation Pharmaceuticals did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Innovation Pharmaceuticals Interest Expense Historical Data

* Premium members only.

The historical data trend for Innovation Pharmaceuticals's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovation Pharmaceuticals Interest Expense Chart

Innovation Pharmaceuticals Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.20 -0.26 -4.86 -0.12 -0.06

Innovation Pharmaceuticals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.01 -0.02 -0.01 -0.01

Innovation Pharmaceuticals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0.06 Mil mean?
Innovation Pharmaceuticals (IPIX) has a Interest Expense of $-0.06 Mil as of Sep. 2023. Interest Expense is the amount a company pays on its long-term debt. View historical data on Innovation Pharmaceuticals and its competitors.
Is Innovation Pharmaceuticals' Interest Expense too high?
Innovation Pharmaceuticals' current Interest Expense is $-0.06 Mil.
How does Innovation Pharmaceuticals' Interest Expense compare to AXIM and RNAZ?
Innovation Pharmaceuticals' Interest Expense of $-0.06 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Innovation Pharmaceuticals and its competitors. Innovation Pharmaceuticals's current Interest Expense is $-0.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovation Pharmaceuticals stock overvalued right now?
Innovation Pharmaceuticals (IPIX) has a current Interest Expense of $-0.06 Mil. The current Interest Expense is $-0.06 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Innovation Pharmaceuticals (IPIX), the current Interest Expense is $-0.06 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovation Pharmaceuticals Business Description

Address 301 Edgewater Place, Suite 100, Wakefield, MA, USA, 01880
Innovation Pharmaceuticals Inc is a clinical-stage pharmaceutical company in the United States. It is engaged in developing therapies with oncology, dermatology, and antimicrobial applications. Its clinical trials focus on evaluating its drug candidates, including Kevetrin for the treatment of cancers; Brilacidin, a potential therapeutic for the treatment of the novel coronavirus. The company focuses on developing small molecule therapies to treat diseases in the areas of cancer, antibiotics, and inflammatory disease.